- Raltegravir (Isentress) is a highly effective and generally safe part of potent combination therapy for HIV infection. There have been rare reports of cases of ...
- Researchers in Sydney, Australia, at St. Vincent’s Hospital and the Kirby Institute for Infection and Immunity in Society have been investigating reports of ...
- Researchers in France reviewed several databases and analysed medical records of HIV-positive participants and found 14 people who were treated very early in ...
- The Visconti study was not the only study to find rare cases of HIV-positive people who can interrupt ART and then have prolonged very low levels of viral load. ...
- At the annual Conference on Retroviruses and Opportunistic Infections (CROI) held in the U.S. in March 2013, researchers presented details of the case of a baby ...
- Vital organs such as the liver and kidneys can become damaged because of the following: . chronic infections that attack the liver (such as hepatitis B virus ...
- Different transplant centres use different protocols specifying which combination of immunosuppressive medicines are used after transplantation. Often, one or ...
- Over the long-term, if immunosuppressive drugs are successful in helping to minimize the immune system’s attack on transplanted tissue, there are several ...
- Researchers at transplant centres across the United States performed kidney transplants in HIV-positive people and subsequently monitored them for three years. ...
- Sirolimus (rapamycin, Rapamune) is currently used as an immunosuppressive medication in transplant patients. However, some research in the past several years ...
- Sirolimus (rapamycin, Rapamune) is an immunosuppressive drug with additional but modest activity against some tumours and HIV. Unlike many other drugs used to ...
- Several transplant drugs interact with medicines used to treat HIV infection, particularly HIV protease inhibitors. These interactions can lead to dangerous ...